Surmodics | SRDX - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 11.16B 300M 2026-03
Align Technology USD 1.04B 10M 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Artivion USD 115.99M 2.6M 2025-12
Baxter International USD 2.7B 270M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
EDAP TMS EUR 13.88M 2.16M 2025-09
Edwards Lifesciences USD 1.65B 80M 2026-03
Haemonetics USD 338.97M 11.97M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
J&J USD 24.1B 500M 2026-03
Merit Medical Systems USD 381.9M 12M 2026-03
Mesa Laboratories USD 62.84M 5.01M 2024-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Option Care Health USD 1.35B 120M 2026-03
Stryker USD 6B 1.2B 2026-03
Surmodics USD 29.57M 355K 2025-06
Trinity Biotech USD 14.31M 1.55M 2025-09